chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash, Rash erythematous
Clinical narrative: after first dosea red prickly feeling rash with asandpaper.in a few days it moved to myshoulders..after a few more days itmoved to my inner thigh...two daysago it moved to my face...one day ago it moved to my neck.; red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to  shoulders, inner thigh, face, neck/ red mottled rash not going away; red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to  shoulders, inner thigh, face, neck/ red mottled rash not going away; after first dose a red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on my upper arms..in a few days it moved to my shoulders..after a few more days it moved to my inner thigh...two days ago it moved to my face; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 24Feb2021 at 08:45 (at the age of 62-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 16Mar2021 at 14:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease, immunoglobulin E high and outdoor and environmental allergies. Concomitant medications included thyroid (ARMOUR THYROID) 120 mg and omalizumab (XOLAIR) twice per month for elevated IGE. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/red mottled rash not going away. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with doxycycline for sores and hydrocortisone ointment for rash. The clinical outcome of the events red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/ red mottled rash not going away was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Vaccination site pain
Clinical narrative: l cannot raise my left arm above my left should because the place of injection is painful; muscle weakness; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 17:00 (at the age of 52-years-old) as a single dose for COVID-19immunisation. The patient did not have any relevant medical history. The patient had no known allergies to any medications, food or other products. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), ezetimibe, simvastatin (VYTORIN) and curcuma longa rhizome (TURMERIC SUPPLEMENT) for unknown indication and on unknown date within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 09Mar2021 at 13:00 (at the age of 52-years-old) as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced that he cannot raise his left arm above his left shoulder because of the place of injection which was painful and had muscle weakness. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the events he cannot raise his left arm above his left shoulder because of the place of injection which was painful and muscle weakness was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Insomnia, Myalgia, Pain in extremity
Clinical narrative: Chills; Grade 2 sore arm, shot occurred too close to shoulder; Insomnia; muscle aches /grade 2 muscle aches; This is a spontaneous report from a contactable healthcare professional, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 07Apr2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and endometriosis. The patient was allergic with codeine and percocet (non-anaphylactic allergies). Concomitant medications included salbutamol (ALBUTEROL), linum usitatissimum seed oil (FLAXSEED OIL), B complex (MANUFACTURER UNKNOWN), C (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 10:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 23:30, the patient experienced grade 2 sore arm (reported as shot occurred too close to shoulder), insomnia, muscle aches and chills about 12 hours after second dose of vaccination. The patient had grade 2 muscle aches the next day. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events insomnia, grade 2 sore arm, muscle aches/grade 2 muscle aches and chills was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Asthenia, Cough, Dizziness
Clinical narrative: Arm pain; Full body weakness; Full body aches; Head aches; Dizziness; anxiety/nervousness; Mental blur; Coughing; soar throat; Joint pain; Runny stuffy nose; sneezing; This is a spontaneous report from a contactable other healthcare professional. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Apr2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient did not have allergies to any medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:30, the patient experienced arm pain, full body weakness and aches, headaches, dizziness, anxiety, nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm pain, full-body weakness and aches, headaches, dizziness, anxiety/nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing were recovered with sequelae.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Oropharyngeal pain, Pain, Pain in extremity
Clinical narrative: Arm pain; Full body weakness; Full body aches; Head aches; Dizziness; anxiety/nervousness; Mental blur; Coughing; soar throat; Joint pain; Runny stuffy nose; sneezing; This is a spontaneous report from a contactable other healthcare professional. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Apr2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient did not have allergies to any medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:30, the patient experienced arm pain, full body weakness and aches, headaches, dizziness, anxiety, nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm pain, full-body weakness and aches, headaches, dizziness, anxiety/nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing were recovered with sequelae.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing
Clinical narrative: Arm pain; Full body weakness; Full body aches; Head aches; Dizziness; anxiety/nervousness; Mental blur; Coughing; soar throat; Joint pain; Runny stuffy nose; sneezing; This is a spontaneous report from a contactable other healthcare professional. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Apr2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient did not have allergies to any medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:30, the patient experienced arm pain, full body weakness and aches, headaches, dizziness, anxiety, nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm pain, full-body weakness and aches, headaches, dizziness, anxiety/nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing were recovered with sequelae.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Pain
Clinical narrative: Dull pain left arm can not touch left hand; Bone ache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 09:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included left hip prothesis and COVID-19. The patient did not have any allergies to food, medications, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 08:00, the patient experienced dull pain left arm cannot touch left hand and bone ache. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. The clinical outcome of the events dull pain left arm cannot touch left hand and bone ache was not recovered at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Feeling abnormal, Pain, Pyrexia
Clinical narrative: Fever; body pain; chills; felt horrible; weak; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 05:00, the patient experienced fever chills felt horrible weak body pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever chills felt horrible weak body pain was resolved in April2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Visual field defect, Visual impairment
Clinical narrative: Impaired vision the evening of the vaccine. Described as wavy or scrambled blind spots. Person thought they were getting a migraine with aura, but never got the migraine/headache.; Impaired vision the evening of the vaccine. Described as wavy or scrambled blind spots. Person thought they were getting a migraine with aura, but never got the migraine/headache.; This is a spontaneous report from a non-contactable consumer. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Medication within two weeks prior to vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced impaired vision the evening of the vaccine. It was described as wavy or scrambled blind spots. The patient thought they were getting a migraine with aura, but never got the migraine/headache. The patient went to bed soon after the impaired vision started and the adverse event ended. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events  impaired vision the evening of the vaccine, described as wavy or scrambled blind spots was resolved on an unknown date in Apr2021at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Rash macular
Clinical narrative: Arm has a warm red splotch below the injection site; Arm has a warm red splotch below the injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 05Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient did not have any allergies to food, medications, or other products. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 15Mar2021 at 09:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced her arm had a warm red splotch below the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events arm has a warm red splotch below the injection site was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Headache, Menstruation irregular, Nausea, Pain
Clinical narrative: Early periods; Severe headache; Nausea; Vomiting; Debilitating body aches; Nose bleed; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00(at the age of 37-year-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient had allergy to shellfish. Concomitant medications included paracetamol (TYLENOL) once from unknown date for unknown indication and melatonin (MANUFACTURER UNKNOWN) once from unknown date for unknown indication . The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 04:00 the patient experienced severe headache, nausea, vomiting, debilitating body aches, nose bleed and it lasted 24 hours. On 8Apr2021 the patient got her period one week early. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe headache, nausea, vomiting, debilitating body aches and nose bleed was recovered on 26Mar2021; while that of got her period one week early was unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Early periods; Severe headache; Nausea; Vomiting; Debilitating body aches; Nose bleed; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00(at the age of 37-year-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient had allergy to shellfish. Concomitant medications included paracetamol (TYLENOL) once from unknown date for unknown indication and melatonin (MANUFACTURER UNKNOWN) once from unknown date for unknown indication . The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 04:00 the patient experienced severe headache, nausea, vomiting, debilitating body aches, nose bleed and it lasted 24 hours. On 8Apr2021 the patient got her period one week early. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe headache, nausea, vomiting, debilitating body aches and nose bleed was recovered on 26Mar2021; while that of got her period one week early was unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Influenza like illness, Pain
Clinical narrative: flu like symptoms; Fever; vomiting; Diarrhea; Chills; Aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on 07Apr2021 at 09:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 09:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, the patient experienced flu like symptoms with fever, vomiting, diarrhoea, chills, aches and fatigue about 52 hours after the second savior. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events flu like symptoms with fever, vomiting, diarrhoea, chills, aches and fatigue were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: flu like symptoms; Fever; vomiting; Diarrhea; Chills; Aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on 07Apr2021 at 09:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 09:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, the patient experienced flu like symptoms with fever, vomiting, diarrhoea, chills, aches and fatigue about 52 hours after the second savior. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events flu like symptoms with fever, vomiting, diarrhoea, chills, aches and fatigue were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 08Apr2021 at 13:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 08Apr2021 at 13:15, the patient experienced dizziness, nausea and extreme fatigue. The patient did not receive any treatment for the events. On an unknown date, the patient underwent nasal swab test and the result was inconclusive. The clinical outcome of the events dizziness, nausea and extreme fatigue were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 20:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. Concomitant therapy includes thyroid meds, progesterone (MANUFACTURER UNKNOWN) and Montelukast sodium (SINGULAIR) from unknown date and for unknown indication. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 19Mar2021 at 15:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 11:00, the patient experienced fatigue, nausea, headache, fever, chills and body aches. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, nausea, headache, fever, chills and body aches were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 20:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. Concomitant therapy includes thyroid meds, progesterone (MANUFACTURER UNKNOWN) and Montelukast sodium (SINGULAIR) from unknown date and for unknown indication. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 19Mar2021 at 15:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 11:00, the patient experienced fatigue, nausea, headache, fever, chills and body aches. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, nausea, headache, fever, chills and body aches were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Severe dizziness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 19:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had none known allergies. Concomitant medication included macrogol 3350 (MIRALAX). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 08:00, the patient experienced severe dizziness. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with over the counter (OTC) medicine. The clinical outcome of the event severe dizziness was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Feeling cold, Influenza virus test, Pain in extremity
Clinical narrative: freezing cold; fever; back ache; heart was beating extraordinarily fast; tired; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the right arm on 03Apr2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to drugs, food or other products. Concomitant medications included birth control from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient has normal symptoms after the vaccine that included tired and sore arm. However on Wednesday, on 07Apr2021 at 05:00, the patient woke up freezing cold, fever, back ache, and her heart was beating extraordinarily fast. The patient got a COVID and flu test which were both negative. The patient went home, slept, took tylenol and relaxed and woke up the next day fine. The patient reported that she started her period that same day and was wondering if that was correlated. On 07Apr2021, the patient underwent PCR and rapid test for COVID-19 of type Nasal Swab and tested negative and also underwent Flu test and tested negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for the reported events and included treatment with Tylenol on 07Apr2021. The clinical outcomes of the events tired and sore arm were recovered on an unknown date in Apr2021 while the outcomes of the events freezing cold, fever, back ache, and heart was beating extraordinarily fast was recovered on 08Apr2021.  No follow-up attempts are needed; no further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pyrexia, SARS-CoV-2 test
Clinical narrative: freezing cold; fever; back ache; heart was beating extraordinarily fast; tired; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the right arm on 03Apr2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to drugs, food or other products. Concomitant medications included birth control from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient has normal symptoms after the vaccine that included tired and sore arm. However on Wednesday, on 07Apr2021 at 05:00, the patient woke up freezing cold, fever, back ache, and her heart was beating extraordinarily fast. The patient got a COVID and flu test which were both negative. The patient went home, slept, took tylenol and relaxed and woke up the next day fine. The patient reported that she started her period that same day and was wondering if that was correlated. On 07Apr2021, the patient underwent PCR and rapid test for COVID-19 of type Nasal Swab and tested negative and also underwent Flu test and tested negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for the reported events and included treatment with Tylenol on 07Apr2021. The clinical outcomes of the events tired and sore arm were recovered on an unknown date in Apr2021 while the outcomes of the events freezing cold, fever, back ache, and heart was beating extraordinarily fast was recovered on 08Apr2021.  No follow-up attempts are needed; no further information is expected.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Joint swelling, Pyrexia, Vaccination site vesicles
Clinical narrative: Blister at site of injection which opened and started stinging; Wrist swelling; Slight temperature increase; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 11:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included colitis, heart stent and valve replacement. Concomitant medications included losartan (MANUFACTURER UNKNOWN), atorvastatin calcium (LIPITOR) and mesalazine (LIALDA), vitamin c (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN)  started on an unknown date for an unknown indication. The patient received augmentin (MANUFACTURER UNKNOWN) for an unknown indication and experienced allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 11:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 (day of injection), the patient experienced fatigue and chills, on 08Apr2021, the patient experienced blister at injection site, wrist swelling, slight temperature increase on second day after vaccine.  No therapeutic measures were taken as a result of these events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event blister at injection site, wrist swelling, slight temperature increase, chills and fatigue was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Muscle pain; Diarrhea; Profuse sweating; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 10:45(at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right arm on 18March2021(at the age of 47-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09April2021 at 02:00, the patient experienced fever, chills, muscle pain, diarrhea and profuse sweating. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, chills, muscle pain, diarrhea and profuse sweating were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Neuralgia, Pain of skin, Sensitive skin, Skin burning sensation
Clinical narrative: Intensely painful skin on upper right leg (neuropathic pain) from hip to knee; Intensely painful skin on upper right leg (neuropathic pain) from hip to knee; Felt like the skin was burned; sleeplessness: woke at 5:30 am after going to bed at 12:30pm on first night; Very sensitive to touch; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic. The patient had no known allergies to medications, food or other products. Concomitant medications included Primadphilus (probiotics) (MANUFACTURER UNKNOWN) and an unspecified B-Complex 12 (MANUFACTURER UNKNOWN) all for an unspecified indications, from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 20:00, the patient experienced intensely painful skin on upper right leg (neuropathic pain) from hip to knee, felt like the skin was burned, very sensitive to touch and sleeplessness (The patient woke at 5:30 am even after going to bed at 12:30 on first night of vaccination) (Not the patient's typical 8 hour sleep pattern)). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events  intensely painful skin on upper right leg (neuropathic pain) from hip to knee, felt like the skin was burned, very sensitive to touch and sleeplessness was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Muscle twitching, Tinnitus
Clinical narrative: Pulsing feeling/noise in right ear; Feels warm; inside of the ear is twitching; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Concomitant medications included levocetirizine dihydrochloride (XYZAL) and venlafaxine hydrochloride (VENLAFAXINE), all from an unknown date, for unknown indications. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021, the patient experienced pulsing feeling/noise in right ear, not consistent like a heartbeat but happened at least once or a few times every minute. The patient felt warm and like the inside of his ear was twitching. No therapeutic measures were taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events pulsing feeling/noise in right ear, feels warm and inside of the ear was twitching was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Nausea
Clinical narrative: Stomach pain; Diarrhea; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included spina bifida and scoliosis. The patient previously had fruits and experienced fruit allergy. Concomitant medications taken within two weeks prior to the vaccination included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) for birth control and fluticasone propionate (FLONASE) for unknown indication, both from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 19:00, the patient experienced stomach pain, diarrhea, nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events stomach pain, diarrhea, nausea was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.